Valuation (24%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 123.68 | N/A |
| PEG Ratio (TTM) | -2.09 | N/A |
| P/S Ratio (TTM) | 5.53 | N/A |
| P/B Ratio (TTM) | 3.31 | N/A |
| P/FCF Ratio (TTM) | 25.44 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.25% | N/A |
| ROE (TTM) | 2.80% | N/A |
| Net Profit Margin (TTM) | 3.89% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -135.20% | 13.63% | N/A |
| Revenue | 1.20% | 5.59% | N/A |
| Net Income | -135.59% | 13.19% | N/A |
| Cash Flow | 87.44% | 1,727.93% | N/A |
Health (56%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.17 | N/A |
| Quick Ratio (TTM) | 2.17 | N/A |
| D/E Ratio (TTM) | 0.76 | N/A |
| Interest Coverage (TTM) | 0.89 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 2.27 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |